Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
C. R. Bard Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
C. R. Bard Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
C. R. Bard Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
C. R. Bard Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
C. R. Bard Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
C. R. Bard Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
C. R. Bard Acquires Technology from 3DT Holdings 12
Venture Financing 13
Embo Medical Raises USD3.7 Million in Seed Funding 13
Vascular Pathways Secures USD5 Million from Square 1 Bank 14
Vascular Pathways Raises USD5.5 Million in Venture Financing 15
NeoMend Secures US$10 Million In Financing 16
Partnerships 17
Boston Scientific Enters into Distribution Agreement with C. R. Bard for Lutonix DCB 17
Equity Offering 18
ClearStream Technologies Completes Private Placement For US$2 Million 18
Debt Offering 19
C. R. Bard Raises USD500 Million in Public Offering of 3% Notes Due 2026 19
C. R. Bard Raises USD500 Million in Public Offering of 1.375% Notes Due 2018 20
Acquisition 21
Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 21
C. R. Bard Acquires Liberator Medical for USD181 Million 23
C. R. Bard Acquires Embo Medical 25
C. R. Bard Acquires 50% Joint Venture Interest in Medicon from Kobayashi Pharma 26
C. R. Bard Acquires Vascular Pathways Europe from MVM Life Science Partners 27
C. R. Bard Acquires Vascular Pathways from MVM Life Science Partners 28
C. R. Bard Completes Acquisition Of Rochester Medical For US$262 Million 29
Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For US$275 Million 31
Davol Completes Acquisition Of Medafor 33
C. R. Bard Acquires Loma Vista Medical 34
C. R. Bard Acquires Neomend, Developer Of Wound Healing Products, For Up To US$165 Million 35
C. R. Bard Acquires Lutonix 37
C. R. Bard Completes Acquisition Of Medivance For US$250 Million 38
C. R. Bard Completes Acquisition Of Clearstream Technologies For US$69 Million 40
Rochester Medical Completes Acquisition Of Laprolan From Fornix BioSciences 42
C. R. Bard Inc – Key Competitors 43
C. R. Bard Inc – Key Employees 44
C. R. Bard Inc – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Recent Developments 51
Financial Announcements 51
Oct 25, 2017: Bard Announces Third Quarter Results 51
Apr 23, 2017: Bard Announces First Quarter Results 53
Jan 26, 2017: Bard Announces Fourth Quarter Results 54
Oct 25, 2016: Bard Announces Third Quarter Results 55
Jul 26, 2016: Bard Announces Second Quarter Results 56
Apr 27, 2016: Bard Announces First Quarter Results 57
Jan 29, 2016: Bard Announces Fourth Quarter Results 58
Legal and Regulatory 59
May 31, 2017: AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access 59
Jan 08, 2016: Seeger Weiss LLP Reports That IVC Filter Lawsuits Against C.R. Bard Have Been Consolidated In A Multidistrict Litigation 60
Product News 61
02/09/2016: New Real-World Comparison Showing Similar Efficacy Between the Lutonix and In.Pact Drug-Coated Balloons Featured at LINC 2016 61
Other Significant Developments 62
Apr 06, 2016: SharedClarity Awards Surgical Mesh Contracts for Breast Reconstructive and Hernia Repair Surgeries 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63
C. R. Bard Inc, Medical Equipment, Key Facts, 2016 2
C. R. Bard Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
C. R. Bard Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
C. R. Bard Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
C. R. Bard Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
C. R. Bard Inc, Deals By Market, 2011 to YTD 2017 9
C. R. Bard Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
C. R. Bard Acquires Technology from 3DT Holdings 12
Embo Medical Raises USD3.7 Million in Seed Funding 13
Vascular Pathways Secures USD5 Million from Square 1 Bank 14
Vascular Pathways Raises USD5.5 Million in Venture Financing 15
NeoMend Secures US$10 Million In Financing 16
Boston Scientific Enters into Distribution Agreement with C. R. Bard for Lutonix DCB 17
ClearStream Technologies Completes Private Placement For US$2 Million 18
C. R. Bard Raises USD500 Million in Public Offering of 3% Notes Due 2026 19
C. R. Bard Raises USD500 Million in Public Offering of 1.375% Notes Due 2018 20
Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 21
C. R. Bard Acquires Liberator Medical for USD181 Million 23
C. R. Bard Acquires Embo Medical 25
C. R. Bard Acquires 50% Joint Venture Interest in Medicon from Kobayashi Pharma 26
C. R. Bard Acquires Vascular Pathways Europe from MVM Life Science Partners 27
C. R. Bard Acquires Vascular Pathways from MVM Life Science Partners 28
C. R. Bard Completes Acquisition Of Rochester Medical For US$262 Million 29
Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For US$275 Million 31
Davol Completes Acquisition Of Medafor 33
C. R. Bard Acquires Loma Vista Medical 34
C. R. Bard Acquires Neomend, Developer Of Wound Healing Products, For Up To US$165 Million 35
C. R. Bard Acquires Lutonix 37
C. R. Bard Completes Acquisition Of Medivance For US$250 Million 38
C. R. Bard Completes Acquisition Of Clearstream Technologies For US$69 Million 40
Rochester Medical Completes Acquisition Of Laprolan From Fornix BioSciences 42
C. R. Bard Inc, Key Competitors 43
C. R. Bard Inc, Key Employees 44
C. R. Bard Inc, Other Locations 46
C. R. Bard Inc, Subsidiaries 47